ImmuPharma plc (LON:IMM – Get Free Report)’s share price traded down 15.2% during mid-day trading on Thursday . The company traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.46 ($0.03). 4,418,779 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 24,563,990 shares. The stock had previously closed at GBX 2.90 ($0.04).
ImmuPharma Trading Down 10.7 %
The company has a 50 day simple moving average of GBX 1.54 and a 200 day simple moving average of GBX 1.68. The stock has a market cap of £10.79 million, a P/E ratio of -259.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Stories
- Five stocks we like better than ImmuPharma
- How to Invest in Small Cap Stocks
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- How to Buy Cheap Stocks Step by Step
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
